Key result
Low serum cholinesterase (<229 U/L), low Geriatric Nutritional Risk Index (<95.6), and low eGFR (<34.2 ml/min/1.73m2) independently and synergistically predicted an increased risk of lethal cardiac events in patients with systolic heart failure.
Why the study?
Assessment and management of nutritional status are important in heart failure, but established indicators are currently lacking.
Cohort (n=1,954)
No
Hazard Ratio: 0.996 (95% CI 0.994–0.998)
p-value: p=<0.0001
Low serum cholinesterase and low Geriatric Nutritional Risk Index (GNRI) are independent predictors of fatal cardiac events in patients with systolic heart failure and renal dysfunction, highlighting the prognostic importance of nutritional assessment.
May support nutritional-renal risk stratification in systolic HF; hypothesis-generating for intervention trials.
Although it is known that assessment and management of the nutritional status of patients are important for treatment of patients with heart failure (HF), there are currently no established indicators. Therefore, we investigated the effects of nutritional parameters as well as conventional parameters on the prognosis of HF patients. A total of 1954 consecutive HF patients with left ventricular ejection fraction (LVEF) less than 50% were enrolled in this study. Transthoracic echocardiography was performed and conventional parameters for HF patients and parameters to assess nutritional status were measured in all patients. Patients were followed up with a primary endpoint of lethal cardiac events (CEs) for 30.2 months. During the follow-up period, cardiac events were documented in 619 HF patients. The CEs group had a lower level of cholinesterase (201.5U/L vs 265.2U/L, P <0.0001), lower estimated GFR (35.2 ml/min/1.73m2 vs 50.3ml/min/1.73m2, P< 0.0001), and lower Geriatric Nutritional Risk Index (GNRI) (91.9 vs 100.0, P< 0.0001) than those in the non-CEs group. Serum cholinesterase, estimated GFR, and GNRI were identified as significant prognostic determinants in multivariate analysis. ROC analyses revealed cut-off values of serum cholinesterase, estimated GFR, and GNRI of 229U/L, 34.2 ml/min/1.73m2, and 95.6, respectively, for identifying high-risk HF patients. HF patients with serum cholinesterase< 229U/L, estimated GFR<34.3 ml/min/1.73m2, and GNRI< 95.6 had a significantly greater rate of CEs than that in the other patients (P<0.0001). Low serum cholinesterase and low GNRI can predict cardiac mortality risk in systolic HF patients with renal dysfunction.
No takes yet. Share an insight, caveat, or question.
Doi et al. (2022) conducted a cohort in Systolic heart failure (n=1,954). Low serum cholinesterase and low Geriatric Nutritional Risk Index (GNRI) vs. Higher serum cholinesterase and GNRI was evaluated on Lethal cardiac events (sudden cardiac death, death from progressive pump failure, fatal ventricular tachyarrhythmias, and appropriate ICD therapy) (HR 0.996, 95% CI 0.994-0.998, p=<0.0001). Low serum cholinesterase (<229 U/L), low Geriatric Nutritional Risk Index (<95.6), and low eGFR (<34.2 ml/min/1.73m2) independently and synergistically predicted an increased risk of lethal cardiac events in patients with systolic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: